Subbu Nambi
Stock Analyst at Guggenheim
(0.16)
# 3,698
Out of 4,667 analysts
19
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Initiates: Neutral | n/a | $15.84 | - | 1 | Oct 17, 2024 | |
| VCYT Veracyte | Initiates: Buy | $40 | $39.36 | +1.63% | 1 | Oct 10, 2024 | |
| GH Guardant Health | Upgrades: Buy | $36 | $30.47 | +18.15% | 3 | Jun 28, 2024 | |
| SOPH SOPHiA GENETICS | Initiates: Buy | $6 | $3.19 | +88.09% | 1 | Jun 27, 2024 | |
| NAUT Nautilus Biotechnology | Initiates: Buy | $6 | $2.36 | +154.24% | 1 | Jun 27, 2024 | |
| TXG 10x Genomics | Downgrades: Neutral | n/a | $13.40 | - | 3 | Jun 26, 2024 | |
| RGEN Repligen | Initiates: Neutral | n/a | $139.61 | - | 1 | Jun 18, 2024 | |
| TWST Twist Bioscience | Initiates: Buy | $53 | $42.53 | +24.63% | 1 | Jun 5, 2024 | |
| CSTL Castle Biosciences | Initiates: Buy | $25 | $29.10 | -14.09% | 1 | Dec 14, 2023 | |
| MYGN Myriad Genetics | Initiates: Buy | $23 | $15.35 | +49.84% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $169.98 | -58.82% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $53.57 | +68.02% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.80 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $136.08 | +13.91% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.19 | - | 1 | Dec 14, 2023 |
GRAIL
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $15.84
Upside: -
Veracyte
Oct 10, 2024
Initiates: Buy
Price Target: $40
Current: $39.36
Upside: +1.63%
Guardant Health
Jun 28, 2024
Upgrades: Buy
Price Target: $36
Current: $30.47
Upside: +18.15%
SOPHiA GENETICS
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.19
Upside: +88.09%
Nautilus Biotechnology
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $2.36
Upside: +154.24%
10x Genomics
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.40
Upside: -
Repligen
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $139.61
Upside: -
Twist Bioscience
Jun 5, 2024
Initiates: Buy
Price Target: $53
Current: $42.53
Upside: +24.63%
Castle Biosciences
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $29.10
Upside: -14.09%
Myriad Genetics
Dec 14, 2023
Initiates: Buy
Price Target: $23
Current: $15.35
Upside: +49.84%
Dec 14, 2023
Initiates: Buy
Price Target: $70
Current: $169.98
Upside: -58.82%
Dec 14, 2023
Initiates: Buy
Price Target: $90
Current: $53.57
Upside: +68.02%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.80
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $155
Current: $136.08
Upside: +13.91%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.19
Upside: -